Price difference as a predictor of the selection between brand name and generic statins in Japan-Reference-Cited by-同舟云学术

Price difference as a predictor of the selection between brand name and generic statins in Japan

Published:2015-05 Issue:5 Volume:119 Page:612-619
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Takizawa Osamu,Urushihara Hisashi,Tanaka Shiro,Kawakami Koji

Publisher

Elsevier BV

Subject

Health Policy

Reference35 articles.

1. Pharmaceutical policies in European countries;Barros;Advances in Health Economics and Health Services Research,2010

2. Does the market share of generic medicines influence the price level?.: a European analysis;Dylst;Pharmacoeconomics,2011

3. Drug prices, out-of-pocket payments, and insurer costs: how do payers vary?;Chen;Advances in Health Economics and Health Services Research,2010

4. Determinants of branded prescription medicine prices in OECD countries;Kanavos;Health Economics, Policy and Law,2011

5. Ministry of Health, Labour and Welfare. Policy Information (English/ Japanese). Retrieved 3 Jan 2015 from 〈http://www.mhlw.go.jp/english/index.html〉.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging themes and factors influencing the prices of biotherapeutics;World Medical & Health Policy;2023-05-02

2. Clinical epidemiology and pharmacoepidemiology studies with real-world databases;Proceedings of the Japan Academy, Series B;2022-12-09

3. Knowledge, Experience, and Perceptions of Generic Drugs among Middle-Aged Adults and their Willingness-to-Pay: A Nationwide Online Survey in Japan;The Tohoku Journal of Experimental Medicine;2021

4. The effect of inertia on brand-name versus generic drug choices;Journal of Economic Behavior & Organization;2020-04

5. Patients’ perspectives on generic substitution among statin users in Japan;Journal of Public Health;2018-04-24